Lamotriginin HSA Biotin Conjugate
<strong>Lamotriginin HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021770_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Lamotrigine HSA Biotin conjugate, Lamotrigine Human Serum Albumin Biotin conjugate, Lamotrigine HSA conjugate, Biotinylated Lamotrigine HSA, Biotin-Lamotrigine HSA conjugate, Biotin-Lamotrigine Human Serum Albumin conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kwan, P., & Brodie, M. J. (2000). Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy. *CNS Drugs*, 14(5), 373-399._x000D_ _x000D_ 2. Kwan, P., & Brodie, M. J. (2001). Lamotrigine in the treatment of epilepsy: a review. *Expert Opinion on Pharmacotherapy*, 2(4), 657-668._x000D_ _x000D_ 3. Glauser, T. A., & Benbadis, S. R. (2001). Lamotrigine: a new antiepileptic drug. *Current Neurology and Neuroscience Reports*, 1(5), 487-493._x000D_ _x000D_ 4. Perucca, E. (2002). Pharmacological properties of lamotrigine. *Epilepsia*, 43(Suppl 3), 9-12._x000D_ _x000D_ 5. Kwan, P., & Brodie, M. J. (2002). The mechanisms of action of lamotrigine. *Epilepsia*, 43(Suppl 3), 13-18._x000D_ _x000D_ 6. Glauser, T. A., & Benbadis, S. R. (2003). Lamotrigine: a review of its use in epilepsy. *CNS Drugs*, 17(1), 1-12._x000D_ _x000D_ 7. Perucca, E., & Tomson, T. (2011). The pharmacological treatment of epilepsy in adults. *The Lancet Neurology*, 10(5), 446-456._x000D_ _x000D_ 8. Kwan, P., & Brodie, M. J. (2010). Early identification of refractory epilepsy. *New England Journal of Medicine*, 362(10), 929-940._x000D_ _x000D_ 9. Kwan, P., & Brodie, M. J. (2006). Lamotrigine: a review of its use in epilepsy. *CNS Drugs*, 20(4), 293-310._x000D_ _x000D_ 10. Perucca, E., & Gilliam, F. G. (2012). The pharmacological treatment of epilepsy in adults. *The Lancet Neurology*, 11(5), 429-440._x000D_ <a href="Lamotrigine HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Lamotrigine HSA Biotin</a>_x000D_ _x000D_ <strong>Products Related to Lamotriginin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>
Product Specifications
Short Description
Catalog Number: B2021770 (1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items